Chris Viehbacher is a renowned German-Canadian businessman.
He served as the Chief Executive Officer of Sanofi and Chairman of Genzyme until 29 October 2014.
After his departure from Sanofi, he worked with Gurnet Point Capital, a healthcare venture capital and private equity fund backed by Ernesto Bertarelli and his family.
Chris was born on March 26, 1960. He has not yet spoken about his parents. However, according to reports, his parents were immigrants.
On Nov. 10, 2022, Chris was appointed President and Chief Executive Officer and a member of the Board of Directors of Biogen Inc. (NASDAQ: BIIB).
Following his appointment, Stelios Papadopoulos, Ph.D., Chairman of the Board of Biogen, said:
“Chris is the rare pharma executive who has a keen understanding of the complexities involved in running a multibillion-dollar global pharma business as well as a deep appreciation for the value of innovation.
“It was the combination of these attributes that enabled him to turn around Sanofi and leave behind a much better company compared to the one he inherited.
“I look forward to Chris leading Biogen to the next chapter of its evolution and, on behalf of the board, I pledge our support to his effort.”
Chris boasts of lot of experience in in both large pharmaceutical companies and entrepreneurial biotech companies.
